11-Jan-2026 3:00 PM CST - Business Wire Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2025, as well as provided 2026 product revenue guidance and select milestones for 2026. 2025 was a remarkable year for Cerus, as patient access to INTERCEPT treated blood components increased meaningfully around the world, said William Obi Greenman, Cerus president and chief executive officer. During 2025, based on the number of kits sold, we
6-Nov-2025 3:01 PM CST - Business Wire Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Product revenue growth was driven by strong global commercial execution and growing awareness of the benefits conferred by
16-Oct-2025 3:00 PM CST - Business Wire Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Rela
21-Aug-2025 7:30 AM CST - Business Wire Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025 Cerus Corporation (Nasdaq: CERS) announced today that company management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 A.M. ET. A live webcast of the fireside chat will be available on the Events and Presentations section of the companys website at ir.cerus.com/events-and-presentations/events-and-webcasts/. A replay will be available for 30 days after the event. ABOUT CERUS Cerus C
5-Aug-2025 3:01 PM CST - Business Wire Cerus Corporation Announces Second Quarter 2025 Financial Results Cerus Corporation (Nasdaq:CERS) announced financial results for the second quarter ended June 30, 2025, and provided a business update. With our singular focus to advance blood safety and availability around the globe by establishing INTERCEPT as the standard of care, this quarters commercial results are evidence of the progress we are making in multiple geographies and across our INTERCEPT product portfolio. The early launch and adoption of our next generati
22-Jul-2025 3:15 PM CST - Business Wire Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relati
3-Jun-2025 3:30 PM CST - Business Wire Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 Cerus Corporation (Nasdaq: CERS) announced today that members of the management team are scheduled to present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, Florida, on Wednesday, June 11, 2025, at 8:40 a.m. Eastern Time. A live webcast of the presentation can be accessed via the Events & Presentation section of Cerus Investor Relations website at ir.cerus.com. A replay of the webcast will be available on Cerus Investor Relati
1-May-2025 3:00 PM CST - Business Wire Cerus Corporation Announces First Quarter 2025 Financial Results Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2025, and provided a business update. We are off to a strong start in 2025, executing against our stated goals and making meaningful progress in advancing Cerus mission to transform the safety and availability of transfused blood components, said William Obi Greenman, Cerus president and chief executive officer. We delivered 13% first quarter product
17-Apr-2025 7:30 AM CST - Business Wire Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Inv
11-Jan-2026 3:00 PM CST - Business Wire Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2025, as well as provided 2026 product revenue guidance and select milestones for 2026. 2025 was a remarkable year for Cerus, as patient access to INTERCEPT treated blood components increased meaningfully around the world, said William Obi Greenman, Cerus president and chief executive officer. During 2025, based on the number of kits sold, we
6-Nov-2025 3:01 PM CST - Business Wire Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Product revenue growth was driven by strong global commercial execution and growing awareness of the benefits conferred by
16-Oct-2025 3:00 PM CST - Business Wire Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Rela
21-Aug-2025 7:30 AM CST - Business Wire Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025 Cerus Corporation (Nasdaq: CERS) announced today that company management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 A.M. ET. A live webcast of the fireside chat will be available on the Events and Presentations section of the companys website at ir.cerus.com/events-and-presentations/events-and-webcasts/. A replay will be available for 30 days after the event. ABOUT CERUS Cerus C
5-Aug-2025 3:01 PM CST - Business Wire Cerus Corporation Announces Second Quarter 2025 Financial Results Cerus Corporation (Nasdaq:CERS) announced financial results for the second quarter ended June 30, 2025, and provided a business update. With our singular focus to advance blood safety and availability around the globe by establishing INTERCEPT as the standard of care, this quarters commercial results are evidence of the progress we are making in multiple geographies and across our INTERCEPT product portfolio. The early launch and adoption of our next generati
22-Jul-2025 3:15 PM CST - Business Wire Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relati
3-Jun-2025 3:30 PM CST - Business Wire Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 Cerus Corporation (Nasdaq: CERS) announced today that members of the management team are scheduled to present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, Florida, on Wednesday, June 11, 2025, at 8:40 a.m. Eastern Time. A live webcast of the presentation can be accessed via the Events & Presentation section of Cerus Investor Relations website at ir.cerus.com. A replay of the webcast will be available on Cerus Investor Relati
1-May-2025 3:00 PM CST - Business Wire Cerus Corporation Announces First Quarter 2025 Financial Results Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2025, and provided a business update. We are off to a strong start in 2025, executing against our stated goals and making meaningful progress in advancing Cerus mission to transform the safety and availability of transfused blood components, said William Obi Greenman, Cerus president and chief executive officer. We delivered 13% first quarter product
17-Apr-2025 7:30 AM CST - Business Wire Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Companys financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Inv
